What is the latest selling price of mitotane in the domestic market?
Mitotane is a drug mainly used to treat adrenocortical cancer and is an adrenocortical inhibitor. It has a positive effect in controlling the progression of cancer by inhibiting the function of the adrenal cortex, thereby reducing the production of adrenal hormones. In recent years, with the deepening of understanding of adrenocortical cancer, the application of mitotane has gradually received attention.
In the domestic market, the original drug of mitotane has been on the market, but due to its short time on the market, the current price has not yet been clarified, and it has not yet been included in the scope of medical insurance, which puts a relatively heavy financial burden on patients. In the international market, the original drug of mitotane is sold in Europe and Turkey. The specification is 500mg per box, usually containing 100 tablets, and the price is about 9,000 yuan. The specific price will change due to exchange rate fluctuations. This price reflects, to a certain extent, the research and development costs and market positioning of mitotane as an anti-cancer drug.

In addition to the original drug, there are also generic drugs for mitotane on the overseas market, especially in countries with lower production costs such as Laos, where the price of the same drug is relatively cheap, usually more than 2,000 yuan. The emergence of such generic drugs provides more choices for some patients with limited economic conditions, although their quality and efficacy may be different from the original drugs.
Overall, mitotane has broad application prospects in China, but due to constraints such as price and medical insurance coverage, patients need to consider comprehensively when choosing to use it. In addition, with the deepening of clinical research and the gradual improvement of policies, the market acceptance and scope of use of mitotane are expected to be further improved. Patients should communicate closely with their doctors during the use of mitotane to ensure the best therapeutic effect while being safe and effective.
Reference materials:https://go.drugbank.com/drugs/DB00648
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)